Cytoreductive surgery was more effective than previous systemic therapies for this patient group.
Abstract
Patients who underwent CC-0 CRS achieved prolonged disease control versus prior systemic therapies, suggesting that CRS may be a management option for highly selected SDH-deficient GIST patients.